Edition:
India

CHF Solutions Inc (CHFS.OQ)

CHFS.OQ on NASDAQ Stock Exchange Capital Market

3.63USD
15 Dec 2017
Change (% chg)

$-0.13 (-3.46%)
Prev Close
$3.76
Open
$3.72
Day's High
$4.03
Day's Low
$3.63
Volume
199,605
Avg. Vol
112,043
52-wk High
$360.00
52-wk Low
$2.87

Select another date:

Wed, Dec 13 2017

BRIEF-CHF Solutions Enters Into International Distribution Agreement With Transmedic Pte Ltd

* CHF SOLUTIONS - ENTERS INTERNATIONAL DISTRIBUTION AGREEMENT WITH TRANSMEDIC PTE LTD TO MARKET & SUPPORT CO'S AQUADEX FLEXFLOW SYSTEM IN SINGAPORE-REGION Source text for Eikon: Further company coverage:

BRIEF-Chiang Li Family Reports A 13.1 Percent Passive Stake In CHF Solutions

* CHIANG LI FAMILY REPORTS A 13.1 PERCENT PASSIVE STAKE IN CHF SOLUTIONS INC AS ON NOV 22 - SEC FILING Source: (http://bit.ly/2AFJcq6) Further company coverage:

BRIEF-CHF SOLUTIONS REPORTS QTRLY LOSS PER SHARE ‍$4.55

* CHF SOLUTIONS, INC. ANNOUNCES 21% REVENUE GROWTH FOR ITS THIRD QUARTER, 2017 AND PROVIDES COMPANY UPDATE

BRIEF-CHF Solutions files for offering of up to $8.0 mln of common stock

* CHF Solutions Inc files for offering of up to $8.0 million of common stock - SEC filing‍​ Source text : (http://bit.ly/2zyK7aG) Further company coverage:

BRIEF-Trend Discovery reports 5.05 pct passive stake in CHF Solutions‍​

* Trend Discovery LP reports 5.05 percent passive stake in CHF Solutions as of Oct 12 - SEC filing‍​ Source text: (http://bit.ly/2gfbEt9) Further company coverage:

BRIEF-CHF SOLUTIONS ANNOUNCES 1 FOR 20 REVERSE SPLIT RATIO

* ‍ANNOUNCED A 1-FOR-20 REVERSE SPLIT OF ITS COMMON STOCK, EFFECTIVE OCT 12 Source text for Eikon: Further company coverage:

BRIEF-CHF Solutions Q2 loss per share $0.47

* CHF Solutions, Inc. announces 18 pct revenue growth for its second quarter and provides company update

BRIEF-CHF Solutions commences manufacturing transition of aquadex flexflow system to its minnesota facility

* has begun process of transitioning manufacturing of aquadex flexflow system from unit of Baxter International to co's facility in minnesota Source text for Eikon: Further company coverage:

BRIEF-CHF's Aquadex Flexflow aquapheresis system receives FDA IDE approval for clinical study for pediatric use

* CHF Solutions’ aquadex flexflow® aquapheresis system receives FDA IDE approval for clinical study for pediatric use Source text for Eikon: Further company coverage:

Select another date: